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Abstract: Cardiovascular disease is the leading cause of death in patients with diabetes therefore 
prompt diagnosis and treatment of high risk groups is essential. Dobutamine stress echocardiog-
raphy is a safe, cheap and reliable method for coronary artery disease diagnosis and provides 
important long term prognostic information. The diagnostic accuracy and prognostic power of 
this technique has been validated by a number of studies on patients with and without diabetes. 
This article discusses the application, interpretation, and accuracy of stress echocardiography 
both in the general population and in patients with diabetes. The role of advanced imaging 
modalites such as myocardial contrast agents and tissue Doppler imaging is also explored.
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Introduction
Patients with diabetes mellitus have a significantly increased risk of ischemic 
cardiovascular mortality and morbidity.1–3 Diagnosis can be difﬁ  cult as the symptoms 
are often atypical and signiﬁ  cant obstructive coronary disease clinically silent. This 
is thought to be in part due to abnormal perception of angina caused by autonomic 
neuropathy. Dobutamine stress echocardiography (DSE) is a widely used tool for both 
ischemic heart disease diagnosis and risk stratiﬁ  cation in different clinical settings. 
This article highlights the principles and practice of this technique and its efﬁ  cacy in 
diabetic patients.
Pathophysiology:   The ischemic cascade
Myocardial ischemia is caused by a transient imbalance between oxygen supply and 
demand, the signs and symptoms of which can be used as a diagnostic tool. A typical 
cascade of events in a well deﬁ  ned time sequence will occur after the onset of ischemia.4 
The forerunner is abnormal myocardial perfusion and endothelial dysfunction, followed 
by regional wall motion dyssynergy, and only at a later stage by electrocardiography 
(ECG) changes and pain. DSE aims to detect regional wall motion abnormalities under 
ischemic conditions and thus allows diagnosis at an earlier stage of the cascade than 
would be achieved by symptoms or ECG changes (Figure 1).
Methodology
The stress agent
Exercise, either via bicycle or treadmill, is the most attractive stress agent as it also 
provides important physiological data. However, this mode of stress is limited in patients 
unable to exercise and requires very rapid acquisition of the echo images. Consequently, 
pharmacological stress is often preferred. Coronary vasodilators such as adenosine and 
dipridamole cause a relative hyperemia with coronary steal to induce ischemia. However, 
they cause relatively less effects on wall motion during stress and are less accurate Vascular Health and Risk Management 2009:5 2
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than inotropic agents such as dobutamine. Thus dobutamine 
remains the pharmacological stress agent of choice in most 
institutions. Pacing induces ischemia by increasing myocardial 
oxygen consumption (due to increased heart rate) and reducing 
myocardial subendocardial perfusion. However, the technique 
is invasive and involves atrial stimulation via the transvenous 
or transoesophageal route so is rarely used.
Image acquisition
Dobutamine is the most often used stress agent as discussed 
above. Ischemia is provoked mainly via the enhanced 
chronotropic and inotropic response to stimulation. 
Transthoracic echo images of the heart are acquired in 
standard parasternal long- and short-axis and apical 2-, 3-, 
4-chamber views at baseline and during stepwise infusion of 
dobutamine. This is given according to a protocol based on 
3 minute stages of 5, 10, 20, 30, 40 μg/kg/min. Atropine can 
be administered up to a total of 1.0 mg intravenously if the 
target heart rate is not achieved with dobutamine alone. Blood 
pressure and 12-lead ECG are recorded at baseline and at each 
infusion stage. Baseline, low-dose (heart 10–15 beats above 
baseline), peak and recovery (10 minutes after drug infusion 
terminated) stage images are acquired as digital loops in a 
quad screen format and stored for off-line analysis. The test is 
stopped if: target heart rate is achieved ([220 – age] × 0.85), 
ST depression 2 mm, signiﬁ  cant tacharrhythmia, symp-
tomatic severe hypotension, blood pressure 240 mmHg 
systolic or 140 mmHg diastolic. Serious side effects are 
rare (1:1000 patients).5 Common minor side effects include 
headache, nausea, shivering, urgency, hypotension. Because 
of the short half life of dobutamine (2 minutes,) there is rapid 
resolution of its effects once the infusion has been stopped.
Interpretation of stress echocardiography
Interpretation is usually by visual assessment based on analysis 
of thickening and inward systolic motion before, during and 
after stress. The heart is typically divided into a 17 segment 
model6 (Figure 2) and a score assigned to each segment at 
baseline and during stress based on the degree of thickening as 
shown in Table 1.7 The presence of a new or worsening regional 
wall motion abnormality in 1 or more segments identiﬁ  es an 
ischemic response. The site of this response gives a clue as to 
the artery affected (Figure 2). The extent of ischemia is based 
on the number of affected segments, the occurrence of ischemia 
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at an early stage of the test,8 the wall motion score index at rest 
and peak stress,9 and a slow recovery time.10 Global left ven-
tricular (LV) ejection fraction and end systolic volumes may 
also be calculated at baseline and at peak stress. A fall in either 
of these parameters is an indicator of signiﬁ  cant ischemia.
This qualitative approach requires signiﬁ  cant training11 
and there are problems with reproducibility in inexperienced 
hands.12 Five percent to 10% of patients will have poor 
acoustic windows such that insufﬁ  cient cardiac segments 
can be analyzed.
Accuracy of stress echocardiography
The accuracy of this technique is consistently reported to 
be good with sensitivity and speciﬁ  city averaging 82% and 
81%, respectively.13 This is comparable to perfusion 
imaging and superior to exercise ECG. As with other 
forms of stress testing, the accuracy is lower in those with 
single vessel disease.14 Accuracy is also reduced in patients 
taking beta blockers although this can be overcome by 
administration of atropine to achieve the target heart rate. 
Advances in image acquisition, analysis, and interpretation 
have enhanced the accuracy and prognostic value of the 
test. Nevertheless, the technique is subjective and inter-
institutional observer agreement remains suboptimal despite 
these advances.15 In assessing the relative merits of which 
test to select for coronary artery disease (CAD) diagnosis 
in any given institution, the overriding consideration must 
always be local expertise.
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Prognostic evaluation
A normal stress echo carries a very low risk (1% per year) 
of major cardiac events in the subsequent 5 years.16 A positive 
stress test carries a 10%–30% risk of further cardiac events, 
with risk being greatest in those with the highest ischemic 
burden.17 The prognostic value of DSE is independent and 
additive to resting echo and exercise ECG.18
Clinical application
Table 2 lists the major uses of DSE in clinical cardiology. In 
all of the above settings the test gives diagnostic and prog-
nostic information. A detailed account of its role in viability 
and valvar heart disease is outside the scope of this review 
article. It is being increasingly used to risk stratify patients 
with no cardiac symptoms awaiting high risk non cardiac 
surgery. This is especially true of patients awaiting major 
vascular surgery19 and in renal transplant candidates,20 where 
there is a high probability of underlying CAD.
New technologies in stress 
echocardiography
Myocardial contrast agents
Left ventricular opaciﬁ  cation with contrast agents injected 
peripherally greatly enhances endocardial border deﬁ  nition.21 
This now allows an accurate diagnosis in patients previously 
considered not suitable for DSE due to poor image quality.22 
Assessment of myocardial perfusion using contrast at rest and 
under stress is also now possible.23 This technique is promis-
ing because a perfusion abnormality would be expected to 
occur before a regional wall motion abnormality in the isch-
emic cascade However, at present its use is limited to a few 
centers only and further standardization of the methodology 
is required before the technique is established.
Coronary ﬂ  ow reserve
Doppler echocardiographic-derived coronary ﬂ  ow reserve 
(CFR) has been studied in diabetic and nondiabetic patients. 
The technique is especially reproducible for the left anterior 
descending artery. Using a CFR cut off value of  or = 2, 
CFR provides independent prognostic information in diabetic 
patients with CAD and a negative dipyridamole stress 
echocardiogram.24
Tissue Doppler and strain rate 
imaging
Tissue Doppler imaging allows assessment of myocardial 
motion in preference to blood ﬂ  ow. Global and regional 
systolic and diastolic velocities can be displayed at rest and 
under stress. The study can thus be quantiﬁ  ed. During isch-
emia, systolic and diastolic velocities are reduced in ampli-
tude with a delayed timing of peak contraction after aortic 
valve closure: post systolic thickening (Figure 3).25 However, 
this technique remains angle-dependent and velocities in a 
given segment of the heart are inﬂ  uenced by tethering to 
adjacent segments and rotational motion of the myocardium 
under stress. This problem can be overcome by assessing 
deformation of the myocardium between 2 segments: strain 
rate imaging.26 While these techniques may improve the 
diagnostic accuracy of stress echo and reduce interobserver 
variability, their use requires considerable expertise and 
machines with high frame rates.
Dobutamine stress 
echocardiography in diabetes
Approximately 50% of mortality in diabetic patients is 
related to CAD.27 Risk of death from cardiovascular disease 
in this population is equivalent to nondiabetics after myo-
cardial infarction.28 Assessing cardiovascular risk in diabetic 
patients is therefore crucial. Sex, lipid levels,29 resting ST 
segment changes are less predictive in diabetes and silent 
ischemia is more common.30 Associated peripheral vascular 
disease and poor exercise capacity make standard exercise 
ECG testing in this group less effective. DSE is therefore 
an attractive method of assessing cardiovascular risk in 
diabetics.
Prognostic evaluation of dobutamine 
stress echo in diabetes
Several studies have shown stress echo is a feasible and 
safe in diabetic patients.31–34 The accuracy is the same 
as for nondiabetics. The presence of inducible regional 
wall motion abnormality under stress is an independent 
predictor of death, incremental to other factors, especially 
resting LV function.32,34 A negative stress echo result is 
associated with a higher mortality (4% per year) than a 
Table 1 The segmental scoring system
Score:
1 = Normal/Hyperkinetic: normal/increased systolic wall motion and 
thickening
2 = Hypokinetic: decreased systolic wall motion and thickening
3 = Akinetic: absent systolic wall motion and thickening
4 = Dyskinetic: outward systolic wall motion and thickening
Notes:   Wall Motion Score Index, Total score of analyzed segments/number segments 
analyzed.Vascular Health and Risk Management 2009:5 5
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similar result in nondiabetics (1% per year). The diabetics 
who die despite a normal stress echo tend to be older, have 
poorer exercise capacity, and have poorer LV function at rest. 
A positive stress echo result in a diabetic is associated with a 
much higher annual mortality (10% per year) than a similar 
result in a nondiabetic (5% per year). Those with impaired 
LV systolic function at rest and a high ischemic burden are 
at greatest risk.32,34
A positive stress ECG is a marker of adverse outcome in 
asymptomatic diabetics. It is also a useful tool for identifying 
high cardiac risk renal transplant candidates.35 In patients 
undergoing major vascular surgery, unrecognized myocar-
dial infarction and silent myocardial ischemia, detected by 
stress echocardiography, are highly prevalent (23% and 28% 
respectively) and are associated with increased long term 
cardiovascular events.36
The timing of serial stress studies in diabetic patients 
with an initial normal stress test is also uncertain. Elhendy 
and colleagues33 have suggested that the cardiac event rate 
is low within 2 years after a stress echo, but after this events 
may occur.
Other techniques for detection 
of coronary disease in diabetics
Nonspecific ST and T wave changes on the 12 lead 
ECG are strong predictors of inducible ischemia in 
asymptomatic diabetic patients. A high coronary calcium score 
(400 Agaston units) from cardiac computed tomography 
(CT) is associated with a high incidence of inducible ischemia 
in diabetic patients.37 Myocardial perfusion imaging also has 
excellent accuracy for CAD diagnosis and event prediction in 
diabetics.38 A normal study is associated with a low event rate 
within the next 2 years. Multislice CT coronary angiography, 
stress magnetic resonance imaging (MRI) and MRI perfusion 
are emerging techniques for CAD detection, but have not been 
extensively investigated in the diabetic population.
Screening for cardiovascular 
disease in diabetes
Advocating which diabetic patients should be investi-
gated for cardiovascular disease remains difﬁ  cult. Only 
5%–10% of asymptomatic diabetics will have obstructive 
Table 2 Indications for dobutamine stress echo
1.   Patients unable to undergo an exercise test or with an inconclusive result due to resting electrocardiogram abnormalities or submaximal heart rate 
achieved.
2. Functional signiﬁ  cance of an angiographically deﬁ  ned stenosis.
3. Risk assessment for major non cardiac surgery.
4. Long term prognosis after acute myocardial infarction.
5.   Viability assessment for contractile reserve in those with poor left ventricular function referred for revascularisation.
6. Loss of contractile reserve in asymptomatic patients with severe valvular regurgitation and normal left ventricular dimensions.
7. Identiﬁ  cation of patients who may beneﬁ  t from surgery with low ﬂ  ow, low gradient aortic stenosis.
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Figure 3 Typical regional velocity response to ischemia seen with tissue doppler imaging. In this example the basal lateral wall velocities are analyzed. At peak stress the 
systolic(s) and diastolic (Em and Am) are reduced. There is also a delayed contraction seen after aortic valve closure (PST).Vascular Health and Risk Management 2009:5 6
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CAD so a universal screening programme for this group 
cannot be justified, particularly as revascularization is 
associated with higher risk than in nondiabetics.39,40 How-
ever, certain patients may beneﬁ  t such as those needing 
renal transplantation20 or major noncardiac surgery.19 In 
these groups coronary revascularization may reduce the 
procedural risk.41 However, diabetics with cardiac symp-
toms, even if atypical, and those with known or suspected 
CAD warrant screening and prognostic evaluation. The 
presence of ischemia during stress echo, especially in those 
with LV dysfunction at rest, permits the identiﬁ  cation of a 
high risk subgroup who should be further investigated and 
treated accordingly. The combination of stress echocar-
diography and a disease speciﬁ  c diabetic cardiac risk score 
may optimize the detection of CAD and cardiac events in 
asymptomatic patients.42
Key messages
•  Cardiovascular disease is the leading cause of death in 
patients with diabetes.
•  DSE is a safe and reproducible technique for CAD 
diagnosis and risk stratiﬁ  cation.
•  Diabetic patients with a positive stress echocardiogram, 
especially if baseline LV systolic function is impaired, 
are at high cardiovascular risk.
•  High risk diabetics should be referred for further cardiac 
investigations and potential revascularization.
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